Paradigm is developing a platform that integrates clinical trial management systems to enhance trial efficiency and reduce participation barriers for both patients and healthcare providers. By creating a unified infrastructure, Paradigm aims to provide equitable access to clinical trials, accelerating the delivery of potentially life-saving therapies.
Funding
$253M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical trials face challenges in efficiency and patient access due to fragmented management systems and high barriers to participation for both patients and healthcare providers. This complexity hinders the development and delivery of potentially life-saving therapies.
Solution
Paradigm offers an intelligent, deep-tech clinical research platform designed to streamline clinical trial management and enhance trial impact. The platform integrates disparate clinical trial management systems, creating a unified infrastructure that reduces physician burden and expands patient access. By optimizing trial design and execution, Paradigm aims to accelerate the delivery of new therapies and improve patient care.
Target Audience
Paradigm primarily targets healthcare providers, clinical research organizations, and pharmaceutical companies seeking to improve the efficiency and accessibility of clinical trials.
Features
- Integration of clinical trial management systems into a unified platform
- AI-driven optimization of clinical trial design for increased efficiency
- Enhanced patient matching algorithms to improve trial enrollment
- Streamlined workflows for healthcare providers to reduce administrative burden
- Tools for monitoring and managing patient participation in clinical trials